NSRX

Nasus Pharma Ltd

Company with tickers: NSRX

CIK

2029039

CUSIP

M7071P109

Shares Outstanding

11,710,808

Website

https://www.nasuspharma.com

13F Activity (30d)

8 filings 6 filers

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Date	Insider	Role	Type	Shares	Price	Value	After
2026-04-22	Teleman Dan Benjamin	Director, Chief Executive Officer	Buy	2,900	$3.76	$10,904	156,991
2026-03-31	Teleman Dan Benjamin	Director, Chief Executive Officer	Buy	15,000	$2.04	$30,600	21,246
2026-03-18	Shacham Sharon	Director	Other	0	—	—	0
2026-03-18	Hershman Ronnie	Director	Other	0	—	—	0
2026-03-18	Rubin Eyal	Chief Financial Officer	Other	0	—	—	0
2026-03-18	Megiddo Dalia	Director, Chief Development Officer	Other	1,888,873	—	—	1,888,873
2026-03-18	Silberman David	Director	Other	0	—	—	0
2026-03-18	Megiddo Dalia	Director, Chief Development Officer	Other	5,195	—	—	5,195
2026-03-18	Teleman Dan Benjamin	Director, Chief Executive Officer	Other	6,246	—	—	6,246
2026-03-18	Gilboa Udi	Insider	Other	5,195	—	—	5,195
2026-03-18	Israel Isaac	Director	Other	0	—	—	0
2026-03-18	Gilboa Udi	Insider	Other	1,919,281	—	—	1,919,281
2026-03-18	Teleman Dan Benjamin	Director, Chief Executive Officer	Other	0	—	—	0
2026-03-18	Hershman Ronnie	Director	Other	909,156	—	—	909,156
2026-03-18	Hershman Ronnie	Director	Other	429,307	—	—	429,307
2026-03-18	Rubin Eyal	Chief Financial Officer	Other	0	—	—	0
2026-03-18	Hershman Ronnie	Director	Other	0	—	—	0
2026-03-18	Gilboa Udi	Insider	Other	0	—	—	0

Showing 1–18 of 18 transactions